These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29794629)

  • 1. Making the case for harm reduction programs for injection drug users.
    Kulikowski J; Linder E
    Nursing; 2018 Jun; 48(6):46-51. PubMed ID: 29794629
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidelines for better harm reduction: evaluating implementation of best practice recommendations for needle and syringe programs (NSPs).
    Strike C; Watson TM; Lavigne P; Hopkins S; Shore R; Young D; Leonard L; Millson P
    Int J Drug Policy; 2011 Jan; 22(1):34-40. PubMed ID: 20413288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syringe exchange.
    Jacobs R; Toynton P
    N J Med; 2003 Sep; 100(9 Suppl):55-9; quiz 79-80. PubMed ID: 14556605
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of a harm-reduction programme on soft tissue infections among injecting drug users of Kolkata, India.
    Bhattacharya MK; Naik TN; Palit A; Bhattacharya SK
    J Health Popul Nutr; 2006 Mar; 24(1):121-2. PubMed ID: 16796159
    [No Abstract]   [Full Text] [Related]  

  • 5. Injecting drug use in India and the need for policy and program change.
    Panda S; Kumar MS
    Int J Drug Policy; 2016 Nov; 37():115-116. PubMed ID: 27771524
    [No Abstract]   [Full Text] [Related]  

  • 6. Harm reduction in the health care system: the legality of prescribing and dispensing syringes to drug users.
    Burris S; Lurie P; Ng M
    Health Matrix Clevel; 2001; 11(1):5-64. PubMed ID: 11345676
    [No Abstract]   [Full Text] [Related]  

  • 7. Measuring effectiveness of needle and syringe exchange programmes for prevention of HIV among injecting drug users.
    Amundsen EJ
    Addiction; 2006 Jul; 101(7):911-2. PubMed ID: 16771880
    [No Abstract]   [Full Text] [Related]  

  • 8. The impact of needle-exchange programs on the spread of HIV among injection drug users: a simulation study.
    Raboud JM; Boily MC; Rajeswaran J; O'Shaughnessy MV; Schechter MT
    J Urban Health; 2003 Jun; 80(2):302-20. PubMed ID: 12791806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam.
    Hammett TM; Wu Z; Duc TT; Stephens D; Sullivan S; Liu W; Chen Y; Ngu D; Des Jarlais DC
    Addiction; 2008 Jan; 103(1):137-45. PubMed ID: 18028519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The art and the science of scaling-up needle and syringe programmes.
    Bedell R
    Addiction; 2007 Aug; 102(8):1179-80. PubMed ID: 17624968
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in injecting practices associated with the use of a medically supervised safer injection facility.
    Stoltz JA; Wood E; Small W; Li K; Tyndall M; Montaner J; Kerr T
    J Public Health (Oxf); 2007 Mar; 29(1):35-9. PubMed ID: 17229788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safer injection facilities (SIFs) for injection drug users (IDUs) in Canada. A review and call for an evidence-focused pilot trial.
    Fischer B; Rehm J; Kim G; Robins A
    Can J Public Health; 2002; 93(5):336-8. PubMed ID: 12353452
    [No Abstract]   [Full Text] [Related]  

  • 13. Needle exchange programs and drug infection behavior.
    DeSimone J
    J Policy Anal Manage; 2005; 24(3):559-77. PubMed ID: 15973795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Operating needle exchange programmes in the hills of Thailand.
    Gray J
    AIDS Care; 1995; 7(4):489-99. PubMed ID: 8547363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syringe-exchange programs and HIV prevention: if they're effective, what's the controversy?
    Villarreal H; Fogg C
    Am J Nurs; 2006 May; 106(5):58-63; quiz 63-4. PubMed ID: 16639248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of combination approach on harm reduction programs: the Taiwan experience.
    Lin T; Chen CH; Chou P
    Harm Reduct J; 2016 Jul; 13(1):23. PubMed ID: 27377896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intravenous drug use and the spread of HIV; an international perspective].
    Meijerink H; van Crevel R; van der Ven AJ
    Ned Tijdschr Geneeskd; 2013; 157(21):A5690. PubMed ID: 23693006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Despite the data, HIV harm reduction programs remain a hard sell in many countries.
    Hoover J
    AIDS; 2003; 17 Suppl 4():S22-4. PubMed ID: 15080176
    [No Abstract]   [Full Text] [Related]  

  • 19. [Services for drug users. Making a difference in many lives].
    Medellín JM
    Sidahora; 2005; ():12-7. PubMed ID: 16634157
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of epidemiology in needle exchange programs.
    Des Vlahov D
    Am J Public Health; 2000 Sep; 90(9):1390-2. PubMed ID: 10983193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.